Question 1

Can a pet DNA test tell me if my pet is sick?

Accepted Answer

Most consumer DNA tests report breed/ancestry, traits, and carrier status or risk markers for some hereditary conditions. Results are information, not a confirmed diagnosis. See a veterinarian if your pet has symptoms or needs a diagnosis.

Question 2

Can I use the results as a diagnosis?

Accepted Answer

No. Consumer DNA tests are not intended for diagnosis. Health and treatment decisions are made by a veterinarian, who may use the results as one piece of information.

Question 3

What should I do once I have the results?

Accepted Answer

Take the report to a general-practice vet and bring the exact variant nomenclature — for example ABCB1 nt230(del4) rather than just “MDR1 positive” — because the specific variant determines what is clinically relevant. In the US your vet can refer you to a board-certified diplomate: ACVIM covers cardiology, internal medicine, neurology and oncology, ACVO covers inherited eye disease. In the UK specialist access is gated by referral and only vets on the RCVS Specialist list may be described as Specialists, so do not try to book a referral centre directly.

Question 4

Will a DNA test affect my pet insurance?

Accepted Answer

Check the policy wording before you test. In the US, Trupanion covers hereditary and congenital conditions on its standard policy provided no signs appeared before the effective date, and Healthy Paws makes the crucial point explicit: a condition does not need to have been diagnosed to count as pre-existing. In the UK the question is whether you hold a lifetime policy such as Petplan’s Covered For Life, which refreshes the annual vet-fee limit at each renewal. None of the insurers we reviewed states that a genetic carrier or risk result on its own creates a pre-existing condition.

Question 5

Which conditions and breeds do you currently cover?

Accepted Answer

For dogs: MDR1/ABCB1 drug sensitivity, degenerative myelopathy (DM/SOD1) and Collie eye anomaly (CEA/NHEJ1). For cats: hypertrophic cardiomyopathy (HCM/MYBPC3) and polycystic kidney disease (PKD/PKD1). Each topic is written for the breeds in which the variant is most relevant.

Question 6

How many sources does each article use?

Accepted Answer

Each article is built on primary literature — typically five or more tier-1/2 references such as PubMed-indexed studies, veterinary journals, and databases like OMIA (Online Mendelian Inheritance in Animals). Every article ends with a reference list you can check.

Question 7

Who writes this site?

Accepted Answer

A non-veterinarian editorial team that synthesizes peer-reviewed research, veterinary journals, and primary sources. We aggregate published evidence and do not diagnose or treat.

Question 8

Is Fur Baby Gene available in other languages?

Accepted Answer

Yes. Fur Baby Gene publishes in English, Japanese (日本語), Simplified Chinese (简体中文) and German (Deutsch). Use the language links in the header. Each language has its own articles written for that market — not machine translations.

English

Lafora Disease (NHLRC1) in the Newfoundland: What the First Confirmed Case Means for This Mid-Popularity Breed

Dermatosparaxis Ehlers-Danlos Syndrome (ADAMTS2) in the American Pit Bull Terrier: What the Research Shows About This Rare Skin-Fragility Disorder

Globoid Cell Leukodystrophy (Krabbe Disease) in the West Highland White Terrier: The GALC Mutation Westies Share With Cairn Terriers

Glycogen Storage Disease IIIa in Curly-Coated Retrievers (AGL): The Second Collapse Gene Your Kennel Club Record Does Not Show

Mucopolysaccharidosis IIIB in Schipperkes (NAGLU): The Variant Nearly One in Four Carried — and the Screening Program That Cut It Back

Narcolepsy in Labrador Retrievers (HCRTR2 c.1105+5G>A): The Splice Variant Behind Collapse on Excitement

JLPP in the Black Russian Terrier (RAB3GAP1): A Recessive Disease You Can Design Out in One Generation

Merle (M Locus / PMEL) in the Catahoula Leopard Dog: 10.3% of Double Merles Were Deaf, Not Two-Thirds — What the BAER Data Actually Says

Vitamin B12 Malabsorption (CUBN) in New Zealand Heading Dogs: the Top Finding of Massey’s 249-Dog Genome Survey — and How to Test from the US, UK and NZ

Hypokalaemia in the Bombay Cat (WNK4): 7% Affected — the Highest Rate of Any Burmese-Derived Breed